MOG and myeloid sarcoma: Abnormal autoantibodies against MOG (27–30) and KIR4.1 (31, 32) reported in some patients with MS; clinical significance remains unclearIgG transfer from MS patients can induce complement-mediated demyelination in animals (27, 42)